Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

6140results about How to "Reduce force" patented technology

Heparin barrier coating for controlled drug release

ActiveUS20050004663A1Reduce frictional forceReduce forceSuture equipmentsStentsCompound (substance)Antioxidant
Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations as well as other therapeutic agents may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. In each of these instances, antioxidants are utilized to prolong product integrity.
Owner:WYETH

Shielded septum trocar seal

The invention is directed to a trocar assembly having a channel defined along an elongate axis, the trocar assembly being adapted to receive a surgical instrument, the trocar assembly comprising a septum seal disposed in the channel including a seal tip having a proximal facing surface, the seal tip including portions defining an orifice; and a septum shield including a tubular member having a proximal end and a distal end, and a plurality of blades or leaflets protruding distally from the distal end of the tubular member, the septum shield being placed inside the septum seal such that the blades engage the proximal facing surface of the seal tip. The trocar assembly may further comprise a zero closure seal such as a double duckbill valve disposed in the channel outside of the septum seal. The septum shield operates to reduce the drag force and to minimize axial movement of the septum shield and the instrument during insertion and removal of the instrument through the septum seal. The septum shield may be formed from a rigid plastic material, and the septum seal may be formed of an elastomeric material. The blades or leaflets may overlap or offset one another. The orifice may be expandable to accommodate the instrument having a diameter of about 5-15 mm. The blades or leaflets have distal tips that glide or roll against the instrument during placement of the instrument. The distal tips may comprise of a combination of material, durometer and shield geometry to control the behavior of the septum shield. The trocar assembly may further comprise a second septum shield disposed outside of the septum seal.
Owner:APPL MEDICAL RESOURCES CORP

Dispenser and cosmetic or dermatological preparation comprising an auxiliary for use with dispenser

The present invention is a cosmetic or dermatological preparation for use with a dispenser that includes an auxiliary to keep the dispenser operating smoothly. The auxiliary is selected from the group consisting of (i) polyols having 2 to 6 carbon atoms and 2 to 6 hydroxyl or alkoxy groups and (ii) surfactants that reduce the surface tension of the preparation to less than 30 mN/m. The preparation is particularly suitable with a dispenser comprising a container and an inner container wall for housing a cosmetic or dermatological preparation; a follow-up plunger on a base side of the dispenser, which is capable of being slidably displaced on the inner container wall under the pressure of the ambient atmosphere; a head section on a top end of the dispenser that can be slidably displaced in relation to the container and that comprises a dispensing channel, the dispensing channel capable of being connected in a communicating manner to the container; a manually actuable delivery device comprising a variable-volume delivery chamber, a delivery element that can be displaced longitudinally in relation to the container and the head section, comprising a delivery plunger that can be slidably displaced within the delivery chamber and a delivery stem connected to the delivery plunger, and a delivery channel circumferentially enclosed by the delivery stem and comprising a delivery-channel inlet opening communicating with the delivery chamber and a delivery-channel outlet opening. The delivery channel outlet opening is capable of being moved into an open position relative to the dispensing channel by displacing the delivery element.
Owner:BEIERSDORF AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products